Join us as we explore new trial data examining Paxlovid's effectiveness in high-risk, vaccinated patients.
The GameChanger
Significantly high-risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccinacated patients.
Host
Jen Moulton, BSPharm
President, CEimpact
Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
New England Journal of Medicine Article
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss EPIC SR study findings.
2. Describe benefits of Paxlovid for specific patient groups based on trial data.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-172-H01-P
Initial release date: 05/13/2024
Expiration date: 05/13/2025
Additional CPE details can be found here.
